Advertisement
Screener

CYTOKINETICS, INCORPORATED (CYTK) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

CYTOKINETICS, INCORPORATED Cash Flow Breakdown

Cash flow breakdown shows where CYTOKINETICS, INCORPORATED's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $510.01M went out.
  • Fiscal year ended 2025-12-31: from investing, $16.67M came in.
  • Fiscal year ended 2025-12-31: from financing, $524.46M came in.
  • Fiscal year ended 2025-12-31: change in cash, $30.40M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$510.01M$16.67M-$10.81M-$2.47M$537.74M*$30.40M
2024-12-31-$395.89M-$553.10M-$8.68M*-$19.63M$958.92M*-$18.17M
2023-12-31-$414.33M$239.25M$0.00*-$10.52M$164.23M$67.60M*$46.22M
2022-12-31-$299.52M-$262.13M-$50.06M*-$9.60M$575.83M*-$45.48M
2021-12-31-$142.52M-$147.78M$0.00*-$4.45M$0.00$324.43M*$29.68M
2020-12-31$8.94M-$196.51M$0.00*-$2.25M$0.00$236.38M*$46.55M
2019-12-31-$90.91M-$74.71M$36.21M$123.58M*-$5.82M
2018-12-31-$101.22M$5.13M$0.00$13.13M*-$82.95M
2017-12-31-$101.76M-$65.83M$112.22M$113.69M*$58.33M
2016-12-31$36.98M-$52.08M$0.00$16.89M*$1.80M
2015-12-31$4.88M$16.06M$8.67M$15.24M*$44.86M
2014-12-31-$44.84M-$4.05M$48.97M$57.00K
2013-12-31-$7.72M-$1.52M$7.45M$7.04M*$5.25M
2012-12-31-$33.44M-$28.82M$43.68M$14.65M*-$3.93M
2011-12-31-$45.59M$25.30M$21.61M*$1.32M
2010-12-31-$44.83M$34.24M-$20.00K$2.57M*-$8.05M
2009-12-31$8.42M-$53.48M$20.00K$28.79M*-$16.26M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$159.84M*-$507.00M*-$3.59M*-$1.49M*$797.94M*
2026-03-31-$145.46M$145.49M-$2.73M-$841.00K$11.35M*$7.32M
2025-12-31-$142.65M*-$71.19M*-$2.72M*-$1.22M*$114.65M*
2025-09-30-$107.50M*-$70.98M*-$2.71M*-$720.00K*$333.89M*
2025-06-30-$128.24M*$52.88M*-$2.70M*-$514.00K*$0.00*$81.74M*
2025-03-31-$131.62M$105.96M-$2.68M-$13.00K$0.00$7.45M*-$21.18M
2024-12-31-$65.57M*$110.86M*-$2.67M*-$1.18M*$6.24M*
2024-09-30-$101.50M*-$45.05M*-$2.66M*$0.00*$6.08M*
2024-06-30-$99.31M*-$651.55M*-$2.65M*$0.00*$823.66M*
2024-03-31-$129.51M$32.64M-$705.00K-$18.45M$93.64M$29.30M*$6.95M
2023-12-31-$74.04M*-$81.41M*$0.00*$0.00*$162.92M*$5.88M*
2023-09-30-$96.20M*$73.04M*$0.00*$0.00*$54.22M*
2023-06-30-$121.81M*$82.13M*$0.00*$0.00*$5.47M*
2023-03-31-$122.29M$165.50M$0.00-$10.52M$0.00$3.34M*$36.03M
2022-12-31-$98.19M*$29.25M*$0.00*$0.00*$29.89M*
2022-09-30-$84.04M*-$292.37M*$0.00*$0.00*$389.02M*
2022-06-30-$90.47M*$65.27M*$0.00*$0.00*$3.42M*
2022-03-31-$26.81M-$64.28M-$50.06M*-$9.60M$153.51M*$2.76M
2021-12-31-$44.74M*$47.34M*$0.00*$19.51M*
2021-09-30-$38.77M*-$208.72M*$0.00*$300.89M*
2021-06-30-$29.50M*$18.88M*$0.00*$3.17M*
2021-03-31-$29.52M-$5.28M$0.00*-$3.60M*-$38.39M
2020-12-31$52.15M*-$173.62M*$0.00*$3.64M*
2020-09-30$14.37M*-$101.02M*$0.00*$226.33M*
2020-06-30-$27.44M*$34.64M*$0.00*$4.16M*
2020-03-31-$30.14M$43.49M$0.00$13.34M
2019-12-31-$19.05M*-$105.27M*$0.00*$121.12M*
2019-09-30-$20.27M*$13.68M*$11.40M*
2019-06-30-$24.68M*-$2.77M*$19.70M*$2.70M*
2019-03-31-$26.91M$19.64M$5.12M-$701.00K*-$2.85M
2018-12-31-$12.33M*$26.51M*$0.00*
2018-09-30-$32.23M*$2.68M*$0.00*$10.23M*
2018-06-30-$26.85M*-$44.19M*$0.00*$2.98M*
2018-03-31-$29.81M$20.14M$0.00-$524.00K*-$10.20M
2017-12-31-$24.07M*$30.76M*$0.00*$2.19M*$8.89M*
2017-09-30-$25.48M*$39.66M*-$8.00K*$1.44M*$15.61M*
2017-06-30-$31.26M*-$23.95M*$94.88M*$11.68M*$51.35M*
2017-03-31-$20.94M-$112.30M$17.36M$98.38M*-$17.51M
2016-12-31$77.83M*-$41.97M*$0.00*$715.00K*$36.57M*
2016-09-30-$12.12M*$13.97M*$0.00*$727.00K*$2.58M*
2016-06-30-$11.22M*-$3.92M*$0.00*$589.00K*-$14.54M*
2016-03-31-$17.51M-$20.16M$0.00$14.86M*-$22.81M
2015-12-31-$9.94M*$25.41M*$8.67M*$14.97M*$39.11M*
2015-09-30-$10.35M*$11.31M*$0.00*$1.12M*
2015-06-30-$9.19M*$11.44M*$0.00*$2.29M*
2015-03-31$34.36M-$32.09M$0.00$2.33M
2014-12-31-$8.13M*$6.30M*$9.10M*$7.31M*
2014-09-30-$9.52M*$10.07M*$0.00*$552.00K*
2014-06-30-$9.38M*$8.44M*$0.00*-$901.00K*
2014-03-31-$17.82M-$28.86M$39.87M-$6.90M
2013-12-31-$12.43M*$5.81M*$0.00*$7.52M*$900.00K*
2013-09-30$10.31M*-$7.59M*-$33.00K*$2.20M*
2013-06-30$6.62M*-$10.21M*$7.48M*$3.90M*
2013-03-31-$12.22M$10.47M-$1.75M
2012-12-31-$7.12M*$6.62M*-$483.00K*
2012-09-30-$8.88M*-$38.97M*-$48.26M*
2012-06-30-$8.70M*-$1.51M*$32.10M$23.95M*$45.84M*
2012-03-31-$8.74M$5.05M$2.67M*-$1.02M
2011-12-31-$10.95M*$8.79M*$2.39M*$242.00K*
2011-09-30-$9.26M*$4.26M*-$5.18M*
2011-06-30-$12.51M*$1.17M*$19.65M*$8.32M*
2011-03-31-$12.88M$11.07M-$2.06M
2010-12-31-$9.09M*-$8.65M*$0.00*$4.81M*-$12.93M*
2010-09-30-$10.32M*$22.76M*$12.07M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Alkermes plc. (ALKS)$6.844B132.74